GWPH - GW Pharmaceuticals plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.59B
Enterprise Value 33.15B
Trailing P/E N/A
Forward P/E 196.02
PEG Ratio (5 yr expected) 13.76
Price/Sales (ttm)27.26
Price/Book (mrq)5.00
Enterprise Value/Revenue 323.97
Enterprise Value/EBITDA 6-14.72

Trading Information

Stock Price History

Beta (3Y Monthly) 2.22
52-Week Change 3-14.71%
S&P500 52-Week Change 38.78%
52 Week High 3196.00
52 Week Low 390.14
50-Day Moving Average 3126.12
200-Day Moving Average 3157.57

Share Statistics

Avg Vol (3 month) 3608.36k
Avg Vol (10 day) 3591.47k
Shares Outstanding 530.89M
Float 29.94M
% Held by Insiders 10.62%
% Held by Institutions 181.95%
Shares Short (Sep. 30, 2019) 43.97M
Short Ratio (Sep. 30, 2019) 46.58
Short % of Float (Sep. 30, 2019) 4N/A
Short % of Shares Outstanding (Sep. 30, 2019) 414.48%
Shares Short (prior month Aug. 30, 2019) 43.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 31, 2018
Most Recent Quarter (mrq)Jun. 30, 2019


Profit Margin -79.40%
Operating Margin (ttm)-170.54%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)131.58M
Revenue Per Share (ttm)4.14
Quarterly Revenue Growth (yoy)2,093.60%
Gross Profit (ttm)-19.8M
EBITDA -214.16M
Net Income Avi to Common (ttm)-104.47M
Diluted EPS (ttm)-3.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)583.68M
Total Cash Per Share (mrq)18.9
Total Debt (mrq)35.25M
Total Debt/Equity (mrq)4.84
Current Ratio (mrq)8.31
Book Value Per Share (mrq)23.60

Cash Flow Statement

Operating Cash Flow (ttm)-289.39M
Levered Free Cash Flow (ttm)N/A